<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01925690</url>
  </required_header>
  <id_info>
    <org_study_id>0033769</org_study_id>
    <secondary_id>National MS Society</secondary_id>
    <nct_id>NCT01925690</nct_id>
  </id_info>
  <brief_title>Development of a Motivational Intervention to Improve Treatment Adherence in MS</brief_title>
  <acronym>MIMS</acronym>
  <official_title>Development of a Motivational Intervention to Improve Treatment Adherence in MS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Missouri, Kansas City</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Multiple Sclerosis Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Missouri, Kansas City</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      As many as 50% of MS patients prematurely discontinue their disease modifying medications.
      For this study, we will develop a telephone-based talk therapy intervention and then conduct
      a randomized controlled trial. Patients will be assigned to either 5 weekly 20 minute
      telephone sessions of psychotherapy or a brief education control condition. We hypothesize
      that patients undergoing phone therapy will be more likely to indicate they are interested in
      resuming taking disease modifying medications than patients given brief education and
      treatment as usual.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence Treatment Survey</measure>
    <time_frame>10 weeks after enrollment</time_frame>
    <description>Whether the patient indicates if he/she decided to re-initiate disease modifying therapies on a &quot;yes&quot;/&quot;no&quot; question.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence Treatment Survey</measure>
    <time_frame>10 weeks after enrollment</time_frame>
    <description>Whether the patient reports that he/she plans to discuss disease modifying therapies with a care provider on a &quot;yes&quot;/&quot;no&quot; question.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence Treatment Survey</measure>
    <time_frame>5 weeks after enrollment</time_frame>
    <description>Whether the patient reports that he/she plans to discuss disease modifying therapies with a care provider on a &quot;yes&quot;/&quot;no&quot; question.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence Treatment Survey</measure>
    <time_frame>5 weeks after enrollment</time_frame>
    <description>Whether the patient indicates if he/she decided to re-initiate disease modifying therapies on a &quot;yes&quot;/&quot;no&quot; question.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Motivation/Readiness Questionnaire</measure>
    <time_frame>10 weeks post-enrollment</time_frame>
    <description>Whether there is increased self-reported motivation to take disease modifying therapies on a 1-10 likert-type scale.</description>
  </other_outcome>
  <other_outcome>
    <measure>Motivation/Readiness Questionnaire</measure>
    <time_frame>5 weeks post-enrollment</time_frame>
    <description>Whether there is an increase in self-reported motivation to take disease modifying therapies on a 1-10 likert-type scale.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Relapsing-remitting Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Brief Education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive a brief educational packet along with treatment as usual</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MI-CBT Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive five 20 minute phone sessions of motivational interviewing/cognitive behavioral therapy weekly along with a brief educational packet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational Interviewing-Cognitive Behavioral Therapy</intervention_name>
    <description>A telephone based talk therapy discussing pros and cons of medication use in MS.</description>
    <arm_group_label>MI-CBT Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Brief Education</intervention_name>
    <description>Give patients a pamphlet discussing pros and cons of disease modifying therapies</description>
    <arm_group_label>Brief Education</arm_group_label>
    <arm_group_label>MI-CBT Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of relapsing remitting MS based on established guidelines

          -  Previously discontinued recommended therapy

          -  Provider recommendation for DMT re-initiation

          -  At least 18 years of age

          -  Access to a telephone

          -  English speaking

        Exclusion Criteria:

          -  Diagnosis other than relapsing remitting MS

          -  Provider does not recommend DMT re-initiation

          -  Pregnant or breastfeeding (females)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jared M Bruce, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Missouri, Kansas City</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Missouri-Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kessler Rehabillitation Institute</name>
      <address>
        <city>West Orange</city>
        <state>New Jersey</state>
        <zip>07052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://sites.google.com/site/clinicalneuropsychologylab/contact-us</url>
    <description>Clinical Neuropsychology Lab Research</description>
  </link>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2013</study_first_submitted>
  <study_first_submitted_qc>August 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2013</study_first_posted>
  <last_update_submitted>November 30, 2015</last_update_submitted>
  <last_update_submitted_qc>November 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Missouri, Kansas City</investigator_affiliation>
    <investigator_full_name>Jared Bruce</investigator_full_name>
    <investigator_title>Associate Professor of Psychology</investigator_title>
  </responsible_party>
  <keyword>Multiple Sclerosis</keyword>
  <keyword>Disease modifying medication</keyword>
  <keyword>Relapsing-Remitting MS</keyword>
  <keyword>Motivational Interviewing</keyword>
  <keyword>Telephone Counseling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis, Relapsing-Remitting</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

